| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,062 |
7,707 |
$4.23M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,107 |
8,905 |
$2.43M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
989 |
921 |
$533K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
270 |
263 |
$194K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,768 |
1,601 |
$158K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,608 |
1,576 |
$121K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
708 |
703 |
$74K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,569 |
1,756 |
$61K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
380 |
372 |
$59K |
| 70450 |
Computed tomography, head or brain; without contrast material |
398 |
385 |
$58K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,548 |
7,586 |
$54K |
| 71045 |
Radiologic examination, chest; single view |
1,840 |
1,698 |
$50K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,430 |
4,021 |
$37K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
110 |
107 |
$27K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,372 |
1,294 |
$24K |
| 71046 |
Radiologic examination, chest; 2 views |
267 |
261 |
$20K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
977 |
843 |
$20K |
| 87070 |
|
1,842 |
1,819 |
$18K |
| 87081 |
|
2,078 |
2,055 |
$16K |
| 80053 |
Comprehensive metabolic panel |
2,320 |
2,132 |
$14K |
| 80076 |
|
1,730 |
1,582 |
$13K |
| 81025 |
|
1,361 |
1,325 |
$13K |
| 0240U |
|
697 |
686 |
$12K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
365 |
356 |
$11K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,419 |
1,285 |
$11K |
| 83690 |
|
1,418 |
1,311 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
458 |
439 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
47 |
46 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
833 |
828 |
$5K |
| 83880 |
|
426 |
362 |
$4K |
| 81001 |
|
1,693 |
1,614 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,120 |
968 |
$4K |
| 84484 |
|
933 |
773 |
$4K |
| 87807 |
|
276 |
274 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
484 |
475 |
$4K |
| 81003 |
|
1,362 |
1,322 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
57 |
55 |
$3K |
| 85610 |
|
1,098 |
971 |
$2K |
| 83735 |
|
730 |
578 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
270 |
257 |
$1K |
| 87088 |
|
205 |
196 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17 |
17 |
$995.49 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
16 |
16 |
$982.95 |
| 36415 |
Collection of venous blood by venipuncture |
9,209 |
8,280 |
$607.34 |
| 80329 |
|
14 |
12 |
$515.15 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
335 |
319 |
$458.78 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
117 |
85 |
$357.11 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
30 |
28 |
$324.41 |
| 84702 |
|
26 |
24 |
$314.11 |
| 80320 |
|
13 |
12 |
$293.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
50 |
47 |
$238.71 |
| 85730 |
|
111 |
102 |
$177.25 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
218 |
160 |
$170.91 |
| 84443 |
Thyroid stimulating hormone (TSH) |
89 |
81 |
$165.77 |
| 99218 |
|
14 |
12 |
$153.95 |
| 86901 |
|
41 |
39 |
$77.29 |
| 86900 |
|
30 |
27 |
$57.47 |
| 80061 |
Lipid panel |
159 |
156 |
$46.03 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
26 |
24 |
$28.96 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
35 |
34 |
$26.73 |
| 82947 |
|
14 |
12 |
$18.83 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
70 |
68 |
$15.91 |
| 80164 |
|
13 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
28 |
27 |
$0.00 |